These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28880374)

  • 1. Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.
    Sachdev V; Sidenko S; Wu MD; Minniti CP; Hannoush H; Brenneman CL; Waclawiw MA; Arai AE; Schechter AN; Kato GJ; Lindner JR
    Br J Haematol; 2017 Nov; 179(4):648-656. PubMed ID: 28880374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
    Quinn CT; Niss O; Dong M; Pfeiffer A; Korpik J; Reynaud M; Bonar H; Kalfa TA; Smart LR; Malik P; Ware RE; Vinks AA; McGann PT
    Br J Haematol; 2021 Aug; 194(3):617-625. PubMed ID: 34227124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia.
    Kumkhaek C; Taylor JG; Zhu J; Hoppe C; Kato GJ; Rodgers GP
    Br J Haematol; 2008 Apr; 141(2):254-9. PubMed ID: 18318767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound detects changes in microvascular blood flow in adults with sickle cell disease.
    Lindner JR; Belcik T; Widlansky M; Harmann LM; Karafin MS; Wandersee NJ; Puligandla M; Neuberg D; Linden J; Field JJ
    PLoS One; 2019; 14(7):e0218783. PubMed ID: 31276520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated fetal haemoglobin levels are associated with decreased incidence of retinopathy in adults with sickle cell disease.
    Mian UK; Tang J; Allende APM; Heo M; Bernstein N; Vattappally L; Schoenfeld D; Minniti CP
    Br J Haematol; 2018 Dec; 183(5):807-811. PubMed ID: 30417925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children.
    Estepp JH; Smeltzer MP; Wang WC; Hoehn ME; Hankins JS; Aygun B
    Br J Haematol; 2013 May; 161(3):402-5. PubMed ID: 23384083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Partanen M; Kang G; Wang WC; Krull K; King AA; Schreiber JE; Porter JS; Hodges J; Hankins JS; Jacola LM
    Br J Haematol; 2020 Jun; 189(6):1192-1203. PubMed ID: 32103506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemoglobin F modulation in childhood sickle cell disease.
    Trompeter S; Roberts I
    Br J Haematol; 2009 Feb; 144(3):308-16. PubMed ID: 19036119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
    Vasavda N; Badiger S; Rees D; Height S; Howard J; Thein SL
    Br J Haematol; 2008 Nov; 143(4):589-92. PubMed ID: 18764867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does HbF induction by hydroxycarbamide work through MIR210 in sickle cell anaemia patients?
    Sawant M; S C; Colah R; Ghosh K; Nadkarni A
    Br J Haematol; 2016 Jun; 173(5):801-3. PubMed ID: 26344186
    [No Abstract]   [Full Text] [Related]  

  • 12. Prior exposure of endothelial cells to hydroxycarbamide alters the flow dynamics and adhesion of sickle red blood cells.
    Verger E; Schoëvaërt D; Carrivain P; Victor JM; Lapouméroulie C; Elion J
    Clin Hemorheol Microcirc; 2014; 57(1):9-22. PubMed ID: 24002118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Regulation of Microvascular Tone in a Murine Model of Sickle Cell Disease Assessed by Contrast Ultrasound.
    Wu MD; Belcik JT; Qi Y; Zhao Y; Benner C; Pei H; Linden J; Lindner JR
    J Am Soc Echocardiogr; 2015 Sep; 28(9):1122-8. PubMed ID: 26123012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N; Fattori A; Saad ST; Costa FF
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
    Flanagan JM; Steward S; Howard TA; Mortier NA; Kimble AC; Aygun B; Hankins JS; Neale GA; Ware RE
    Br J Haematol; 2012 Apr; 157(2):240-8. PubMed ID: 22360576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.
    Nottage KA; Ware RE; Aygun B; Smeltzer M; Kang G; Moen J; Wang WC; Hankins JS; Helton KJ
    Br J Haematol; 2016 Oct; 175(2):331-338. PubMed ID: 27604981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
    Iyamu EW; Cecil R; Parkin L; Woods G; Ohene-Frempong K; Asakura T
    Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.
    Brandow AM; Wandersee NJ; Dasgupta M; Hoffmann RG; Hillery CA; Stucky CL; Panepinto JA
    Br J Haematol; 2016 Oct; 175(2):237-245. PubMed ID: 27539682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
    Lapouméroulie C; Benkerrou M; Odièvre MH; Ducrocq R; Brun M; Elion J
    Haematologica; 2005 Mar; 90(3):401-3. PubMed ID: 15749673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.